Evidence map›Paper›PMID 33667309›Full record

Trial reportThe international journal of neuropsychopharmacology2021

The Influence of Acute SSRI Administration on White Matter Microstructure in Patients Suffering From Major Depressive Disorder and Healthy Controls.

R Seiger, G Gryglewski, M Klöbl, A Kautzky, G M Godbersen, L Rischka, T Vanicek, M Hienert, J Unterholzner, L R Silberbauer and 5 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled TrialClinical Trial, Phase IV
In one paragraph

Trial report in The international journal of neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02711215 (Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging), which is not on this map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02711215 phase4unknown statusnot on this map

Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)

TypeinterventionalSponsorMedical University of ViennaRan2015 to 2020Enrolled80ConditionsMajor Depressive DisorderArmsPET/MR [11C]DASB, Citalopram, Escitalopram (Mirtazapine/Duloxetine/Venlafaxine), Placebo
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

R SeigerDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
G GryglewskiDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
M KlöblDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
A KautzkyDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
G M GodbersenDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
L RischkaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
T VanicekDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
M HienertDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
J UnterholznerDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
L R SilberbauerDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-8521-1012
P MichenthalerDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
P HandschuhDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
A HahnDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
S KasperDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
R LanzenbergerDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-4641-9539
Medical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSelective serotonin reuptake inhibitors (SSRIs) are predominantly prescribed for people suffering from major depressive disorder. These antidepressants exert their effects by blocking the serotonin transporter (SERT), leading to increased levels of serotonin in the synaptic cleft and subsequently to an attenuation of depressive symptoms and elevation in mood. Although long-term studies investigating white matter (WM) alterations after exposure to antidepressant treatment exist, results on the acute effects on the brain's WM microstructure are lacking.

methodsIn this interventional longitudinal study, 81 participants were included (33 patients and 48 healthy controls). All participants underwent diffusion weighted imaging on 2 separate days, receiving either citalopram or placebo using a randomized, double-blind, cross-over design. Fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity were calculated within the FMRIB software library and analyzed using tract-based spatial statistics.

resultsThe repeated-measures ANOVA model revealed significant decreases after SSRI administration in mean diffusivity, axial diffusivity, and radial diffusivity regardless of the group (P < .05, family-wise error [FWE] corrected). Results were predominantly evident in frontal WM regions comprising the anterior corona radiata, corpus callosum, and external capsule and in distinct areas of the frontal blade. No increases in diffusivity were found, and no changes in fractional anisotropy were present.

conclusionsOur investigation provides the first evidence, to our knowledge, that fast WM microstructure adaptations within 1 hour after i.v. SSRI administration precede elevations in mood due to SSRI treatment. These results add a new facet to the complex mode of action of antidepressant therapy. This study was registered at clinicaltrials.gov with the identifier NCT02711215.

Indexed as

AdultDiffusion Tensor ImagingFemaleHumansLongitudinal StudiesMajor Depressive DisorderMaleSelective Serotonin Reuptake InhibitorsWhite MatterYoung AdultSelective Serotonin Reuptake Inhibitorsdepressiondiffusion tensor imagingSelective serotonin reuptake inhibitorstract-based spatial statisticswhite matter

Identifiers

PMID33667309
PMCPMC8299824
OpenAlexW3135200158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.